Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints-Reference-Cited by-同舟云学术

Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints

Published:2018-10 Issue:2 Volume:102 Page:296-303
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Meier Robert M.,Bloch Daniel A.,Cotrutz Cristian,Beckman Alan C.,Henning George T.,Woodhouse Shermian A.,Williamson Shirnett K.,Mohideen Najeeb^ORCID,Dombrowski John J.,Hong Robert L.,Brachman David G.,Linson Patrick W.,Kaplan Irving D.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference37 articles.

1. 70 Gy versus 80 Gy in localized prostate cancer: 5-Year results of GETUG 06 randomized trial;Beckendorf;Int J Radiat Oncol Biol Phys,2011

2. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: Long-term results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol,2014

3. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol,2007

4. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial;Pollack;Int J Radiat Oncol Biol Phys,2002

5. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of intra-fractional positioning correction performed by cone beam computed tomography in SBRT treatments;Physica Medica;2024-09

2. Intrafractional motion and dosimetric analysis in prostate stereotactic body radiation therapy with auto beam hold technique;Biomedical Physics & Engineering Express;2024-06-26

3. Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate Cancer;International Journal of Particle Therapy;2024-06

4. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

5. Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate–High-Risk Prostate Cancer: Insights from a Phase I/II Study;Cancers;2024-05-31